
Anti-Obesity Medications Change Conversation for Bariatric Surgery
Anti-obesity medications (AOMs) are having a powerful impact worldwide. The glucagon-like peptide-1 (GLP-1) receptor agonist Ozempic (semaglutide) is so popular that the economy of Denmark, where Novo Nordisk produces the drug, now hinges on the drug’s …